Clinical Trials Logo

Childhood Cancer clinical trials

View clinical trials related to Childhood Cancer.

Filter by:

NCT ID: NCT05641961 Recruiting - Clinical trials for Malignant Solid Neoplasm

Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

Start date: November 29, 2022
Phase: N/A
Study type: Interventional

This clinical trial studies the effectiveness of a newly developed survivorship mobile application (app) designed for survivors, or their caregivers, of childhood cancer to help them better navigate long-term follow-up care. The survivorship app provides survivors access to their treatment history and follow-up recommendations, improves knowledge of their diagnosis, treatment, risks, and recommended follow-up care by using a message notification. The ability to quickly connect and establish care planning may enhance adherence to recommended follow-up.

NCT ID: NCT05617391 Recruiting - Childhood Cancer Clinical Trials

An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks

Start date: December 13, 2022
Phase:
Study type: Observational

The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer. Primary Objective To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk. Secondary Objective To build a novel predictive model solely on smartwatch ECG to predict risk for cardiomyopathy.

NCT ID: NCT05582551 Recruiting - Childhood Cancer Clinical Trials

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Start date: August 2, 2023
Phase: N/A
Study type: Interventional

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

NCT ID: NCT05504772 Recruiting - Childhood Cancer Clinical Trials

Precision Medicine for Every Child With Cancer

ZERO2
Start date: December 16, 2022
Phase:
Study type: Observational

To improve outcomes for childhood cancer patients through the implementation of precision medicine.

NCT ID: NCT05481229 Recruiting - Childhood Cancer Clinical Trials

Nutrition Childhood Cancer Survivors

Start date: April 25, 2018
Phase:
Study type: Observational

NUTRITION CCS is a cross-sectional, descriptive study to assess the relationship between body composition and demographic, socioeconomic status, treatment modalities and blood samples of survivors who were in remission. The study was conducted in the Clinic for childhood cancer survivors. The clinic is attended by patients older than 18 years and was built in 2016 at the St. Anne's Hospital in Brno.

NCT ID: NCT05478850 Completed - Childhood Cancer Clinical Trials

Inadvertent Hypothermia or Hyperthermia in Pediatric Radiotherapy Practices Under Anesthesia

Start date: August 1, 2022
Phase:
Study type: Observational

In prospective, observational cohort study, changes in body temperature will be investigated before the procedure and during recovery in Radiotherapy patients aged 0-18 years who need sedation due to childhood malignancies. The aims of this study were to measure the incidence and magnitude of changes in body temperature in children undergoing sedation or general anesthesia for Radiotherapy, and to determine their effects on the recovery process.

NCT ID: NCT05457153 Not yet recruiting - Childhood Cancer Clinical Trials

Technology-Based Well-Being Process Program (WEBEPROP) for Children and Adolescents in Palliative Care

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Objective: The research was planned to evaluate the effectiveness of the 8-week technology-based Well-Being Process program for children and adolescents in the palliative care period. Methods: This study was planned as a randomized controlled experimental study. The research will be carried out with children aged 12-20 years with a diagnosis of cancer, in the pediatric oncology and hematology clinics of two hospitals in Turkey. Data collection will consist of the children and adolescent's and parents' descriptive characteristic form Adolescent Spiritual Well-Being Scale, Beck Anxiety Scale, Pediatric Cancer Coping Scale and Technology-Based Spiritual Care Program Process Evaluation Forms. The program will be implemented for the intervention group. In the 8-week program; a) 4 web-based modules, b) 8 online individual interviews after each module (8 total interviews with each child) c) simultaneous mobile messages with the modules, and d) 24/7 counseling. Animation videos, breathing and progressive relaxation exercises, and imagination methods will be included in the modules. This research is based on the "Watson Model of Human Care".

NCT ID: NCT05448560 Recruiting - Clinical trials for Health Knowledge, Attitudes, Practice

A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship

BRIDGES
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

More than 80% of childhood cancer survivors develop serious or life-threatening late effects after cancer therapy, but <20% receive recommended survivorship care offered at cancer center survivorship clinics. In a shared care model, the investigators propose to investigate an innovative multi-level intervention consisting of: 1) patient survivorship education via telehealth with the cancer center, 2) ongoing patient-tailored education program within the electronic health record patient portal, 3) a structured interactive phone communication between the cancer center and the primary care clinic, and 4) an in-person visit with the primary care clinic for survivorship care with the goal of achieving high rates of adherence to recommended surveillance for late effects, as well as improving patient and physician knowledge and self-efficacy. If this scalable intervention demonstrates patient completion of recommended care comparable to cancer center survivorship clinics, this innovative study has the enormous potential to deliver recommended care to a larger proportion of childhood cancer survivors and reduce survivorship care disparities, while engaging p to integrate survivorship care as part of overall, lifelong health maintenance.

NCT ID: NCT05372536 Recruiting - Childhood Cancer Clinical Trials

Home Chemotherapy Intervention for Children With Cancer - a Feasibility Study

INTACTatHome
Start date: March 11, 2022
Phase: N/A
Study type: Interventional

Children with cancer undergo intensive treatment with many serious side effects and frequent in- and outpatient visits. Studies show that the frequent hospitalizations are very disruptive to children and their families, who strive to maintain a normal everyday life. The aim of the study is to test a parent-led home-administered low-dose cytarabine intervention that will not compromise the quality of treatment and care, increase the caregiver burden or the experienced symptoms of the children. The methodical approach is based on The Medical Research Council's framework to develop and evaluate complex interventions in health care using both clinical observational methods, participatory methods, surveys and qualitative ethnographic methods. The overall goal of the project is to support and ease the everyday lives of children with cancer and their families during the intensive treatment periods.

NCT ID: NCT05342155 Recruiting - Survivorship Clinical Trials

Patient- Generated Health Data to Predict Childhood Cancer Survivorship Outcomes

Start date: March 20, 2023
Phase:
Study type: Observational

Some childhood cancer survivors have health problems as the result of previous cancer treatment. This study is being done to determine if we can better predict the risk a childhood cancer survivor might have for developing future health issues. The goal of this study is to enable regular monitoring of patient-generated health data (PGHD), including symptoms, physical activity, energy expenditure, sleep behavior and heart rate variability, and utilize these data in predicting survivor-specific risk of late effects to improve survivorship care and outcomes.